Fuan Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 2,780.740 million compared to CNY 2,669.296 million a year ago. Operating income was CNY 326.593 million compared to operating loss of CNY 321.142 million a year ago. Net income was CNY 292.829 million compared to net loss of CNY 359.976 million a year ago. Basic earnings per share from continuing operations was CNY 0.25 compared to basic loss per share from continuing operations of CNY 0.3 a year ago.